Povidone-iodine and antibiotics effective for cataract surgery

Article

Preoperative povidone-iodine and postoperative intracameral antibiotic injections are recommended for endophthalmitis prophylaxis, claims a recent paper.

Preoperative povidone-iodine and postoperative intracameral antibiotic injections are recommended for endophthalmitis prophylaxis, claims a recent paper.

Dr J. Vazirani et al., Cornea and Anterior Segment Services, L V Prasad Eye Institute, Hyderabad, Andhra Pradesh, India, conducted a review on the results of a European multicentre trial documenting a reduced risk of endophthalmitis with postoperative intracameral cefuroxime injections. The assessment also included studies from worldwide multicentre studies on the benefits of intracameral antibiotics.

It was discovered that intracameral antibiotics are becoming routine protocol after cataract surgery. However, the application of povidone-iodine before cataract surgery remains a universal practice.

The most popular form of antibiotic prophylaxis is topical fluoroquinolone application and the most promising approach is the development of novel drug delivery for sustained antibiotic release.

The abstract can be found in the Current Opinion in Ophthalmology.

If you are interested in this topic you can read more information on the use of intracameral antibiotics to prevent post-op endophthalmitis following cataract surgery here.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
© 2025 MJH Life Sciences

All rights reserved.